Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s

wired.com/story/lilly-obesity-pill-effective-orforglipron-injected-glp-1-ozempic

Eli Lilly’s daily anti-obesity pill orforglipron appears to be as good at spurring weight loss and lowering blood sugar in diabetes patients as popular injectable GLP-1 drugs like Ozempic, according to new data from a Phase 3 trial. The results were announced today at the annual meeting…

This story appeared on wired.com, 2025-06-21 15:25:52.533000.
The Entire Business World on a Single Page. Free to Use →